Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F22%3A10449456" target="_blank" >RIV/00216208:11150/22:10449456 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/22:10449456
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=MI~KyWPqCb" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=MI~KyWPqCb</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1182/bloodadvances.2022007812" target="_blank" >10.1182/bloodadvances.2022007812</a>
Alternative languages
Result language
angličtina
Original language name
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Original language description
Venetoclax is an effective therapy for chronic lymphocytic leukemia (CLL) with the potential to induce deep remissions.1-5 Furthermore, venetoclax in combination with an anti-CD20 antibody is now approved on fixed-duration treatment schedules (front-line: 12 months with obinutuzumab3 ; relapsed/refractory: 24 months with rituximab).2 As fixed-duration venetoclax-based therapies are increasingly used, more patients will require CLL therapy after venetoclax.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Blood Advances
ISSN
2473-9529
e-ISSN
2473-9537
Volume of the periodical
6
Issue of the periodical within the volume
15
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
4553-4557
UT code for WoS article
000851364100024
EID of the result in the Scopus database
2-s2.0-85135485099